Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:breast_cancer_subtype
|
| gptkbp:associatedWith |
aggressive tumor behavior
poor prognosis (without targeted therapy) |
| gptkbp:characteristic |
high HER2 expression
low estrogen receptor expression low progesterone receptor expression |
| gptkbp:commonIn |
younger women
|
| gptkbp:compatibleWith |
basal-like
luminal A luminal B |
| gptkbp:definedIn |
gene expression profiling
|
| gptkbp:isFrequently |
node positive at diagnosis
|
| gptkbp:isIdentifiedBy |
PAM50 assay
|
| gptkbp:isLessLikelyToExpress |
hormone receptors
|
| gptkbp:subspecies |
gptkb:cancer
|
| gptkbp:treatment |
gptkb:pertuzumab
gptkb:trastuzumab gptkb:lapatinib chemotherapy HER2-targeted therapy |
| gptkbp:bfsParent |
gptkb:HER2-positive_breast_cancer
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
HER2-enriched
|